Purine nucleoside phosphorylase
AltitudeomicsDB
Protein Official symbol |
PNP |
Aliases |
PNP NP |
Chromosomal Location |
14 |
Length |
289 |
Uniprot ID |
P00491 |
EC number |
2.4.2.1 |
Protein family Information(Pfam) |
PF01048; |
PDB id |
1M73;1PF7;1PWY;1RCT;1RFG;1RR6;1RSZ;1RT9;1ULA;1ULB;1V2H;1V3Q;1V41;1V45;1YRY;2A0W;2A0X;2A0Y;2OC4;2OC9;2ON6;2Q7O;3BGS;3D1V;3GB9;3GGS;3INY;3K8O;3K8Q;3PHB;4EAR;4EB8;4ECE;4GKA;5ETJ;5UGF; |
InterPro ID |
IPR000845;IPR035994;IPR011270;IPR011268;IPR018099; |
dbSNP |
rs1049564 rs104894453 rs104894450 rs104894454 rs104894452 rs104894451 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
ADA |
PNP |
0.996 |
ADA |
ADK |
0.995 |
APRT |
ADK |
0.991 |
PNP |
ADK |
0.989 |
CDA |
DCK |
0.986 |
APRT |
GDA |
0.984 |
APRT |
PNP |
0.984 |
PNP |
GDA |
0.984 |
APRT |
HPRT1 |
0.983 |
CDA |
TK1 |
0.98 |
NT5C3A |
NT5C |
0.979 |
PNP |
UPP1 |
0.979 |
CDA |
UPP1 |
0.977 |
UPRT |
UPP1 |
0.976 |
CDA |
PNP |
0.976 |
DPYD |
UPP1 |
0.976 |
PNP |
HPRT1 |
0.974 |
NAPRT |
NMRK1 |
0.973 |
ADA |
NT5E |
0.971 |
NT5C2 |
DCK |
0.968 |
ADK |
NT5E |
0.968 |
PGM2 |
PNP |
0.964 |
PNP |
DCK |
0.963 |
PNP |
NMRK1 |
0.963 |
ADA |
DCK |
0.962 |
UPP2 |
CDA |
0.961 |
XDH |
GDA |
0.959 |
UPRT |
PNP |
0.958 |
NMRK1 |
NAMPT |
0.958 |
NAPRT |
PNP |
0.958 |
DPYD |
PNP |
0.957 |
CECR1 |
PNP |
0.957 |
NMRK2 |
NAPRT |
0.956 |
CECR1 |
ADK |
0.956 |
NT5C2 |
NT5C1A |
0.956 |
UPP2 |
PNP |
0.955 |
PNP |
DGUOK |
0.955 |
UPP2 |
UPRT |
0.953 |
HPRT1 |
GDA |
0.953 |
NT5C3A |
NT5C2 |
0.952 |
XDH |
PNP |
0.951 |
APRT |
DCK |
0.949 |
UPP2 |
DPYD |
0.948 |
UPP1 |
TK1 |
0.946 |
CDA |
NT5C2 |
0.945 |
NT5C3B |
NT5C1B |
0.945 |
PNP |
NT5C2 |
0.945 |
CECR1 |
ADA |
0.945 |
UPRT |
DPYD |
0.944 |
NT5C3A |
NT5C1A |
0.944 |
NT5C3B |
NT5C1A |
0.944 |
NT5C |
NT5C1A |
0.944 |
NT5C3A |
DCK |
0.943 |
CD38 |
NAMPT |
0.941 |
DCK |
NT5C |
0.94 |
PNP |
NT5E |
0.94 |
PNP |
NAMPT |
0.939 |
BST1 |
NAMPT |
0.939 |
UPP1 |
TK2 |
0.938 |
NT5M |
DCK |
0.938 |
NMRK2 |
PNP |
0.937 |
PNP |
TK1 |
0.937 |
NT5C2 |
ADK |
0.937 |
UPP2 |
TK1 |
0.937 |
NNMT |
NAMPT |
0.936 |
NMRK2 |
NAMPT |
0.935 |
ADA |
NT5C2 |
0.935 |
NT5C1B |
NT5C |
0.934 |
NT5M |
NT5C1A |
0.933 |
DCK |
NT5C1A |
0.932 |
CDA |
NT5E |
0.932 |
UPP2 |
TK2 |
0.932 |
NT5C2 |
NT5C |
0.932 |
NT5M |
DGUOK |
0.931 |
NT5C1B |
NT5C2 |
0.931 |
CDA |
NT5C |
0.931 |
XDH |
HPRT1 |
0.929 |
APRT |
NT5E |
0.929 |
NT5M |
NT5C1B |
0.928 |
TK1 |
TK2 |
0.927 |
NT5C3A |
CDA |
0.927 |
HPRT1 |
NT5E |
0.926 |
TK1 |
NT5C |
0.926 |
NT5C1B |
DCK |
0.925 |
PNP |
BST1 |
0.924 |
NNMT |
CD38 |
0.923 |
PNP |
NT5C1A |
0.923 |
ADK |
NT5C1A |
0.923 |
NT5M |
NT5C2 |
0.923 |
UPRT |
NT5E |
0.922 |
NT5C3A |
NT5C1B |
0.921 |
ADA |
NT5C1A |
0.921 |
NT5C2 |
HPRT1 |
0.921 |
DCK |
NT5E |
0.92 |
NT5C3B |
PNP |
0.92 |
CDA |
NT5C1A |
0.918 |
NT5C3B |
NT5C2 |
0.918 |
NT5C3B |
ADK |
0.917 |
NT5C3A |
PNP |
0.917 |
NT5C3B |
NT5M |
0.915 |
NT5E |
NAMPT |
0.915 |
NT5C3B |
DCK |
0.915 |
ADA |
NT5C |
0.914 |
PNP |
CD38 |
0.914 |
NNMT |
BST1 |
0.914 |
PNP |
NT5C |
0.913 |
BST1 |
CD38 |
0.913 |
NT5C1B |
ADK |
0.913 |
NT5C3A |
ADA |
0.912 |
NNMT |
PNP |
0.911 |
NT5M |
NT5E |
0.911 |
APRT |
NT5C2 |
0.91 |
CDA |
TK2 |
0.91 |
NT5M |
ADK |
0.91 |
NT5M |
ADA |
0.908 |
NT5C3B |
ADA |
0.907 |
HPRT1 |
NT5C1A |
0.907 |
APRT |
NT5C |
0.907 |
APRT |
NT5C1A |
0.907 |
NT5M |
CDA |
0.906 |
NT5C3B |
NAMPT |
0.906 |
NT5C3A |
ADK |
0.905 |
NT5C3A |
NAMPT |
0.905 |
ADA |
NT5C1B |
0.904 |
NT5M |
APRT |
0.904 |
NT5M |
NAMPT |
0.903 |
NT5M |
PNP |
0.903 |
NAPRT |
NT5C |
0.903 |
UPRT |
NT5C |
0.903 |
PNP |
NT5C1B |
0.902 |
ENSG00000250741 |
APRT |
0.902 |
ADK |
NT5C |
0.902 |
NAPRT |
NT5C3B |
0.902 |
NT5C2 |
NAMPT |
0.902 |
NT5C3B |
HPRT1 |
0.902 |
PNP |
TK2 |
0.902 |
APRT |
NT5C1B |
0.902 |
ENSG00000250741 |
PNP |
0.902 |
NAPRT |
NT5M |
0.902 |
HPRT1 |
NT5C |
0.902 |
NT5C3A |
NAPRT |
0.902 |
NT5C3A |
HPRT1 |
0.902 |
NAPRT |
NT5C1A |
0.901 |
NT5C |
NAMPT |
0.9 |
CECR1 |
DCK |
0.9 |
ENSG00000250741 |
NAMPT |
0.9 |
ENSG00000250741 |
NAPRT |
0.9 |
ENSG00000250741 |
ADA |
0.9 |
NT5M |
HPRT1 |
0.9 |
NT5C3B |
CDA |
0.9 |
NAPRT |
NT5C1B |
0.9 |
NT5M |
UPRT |
0.9 |
NAPRT |
NT5C2 |
0.9 |
NT5C3A |
APRT |
0.9 |
NAPRT |
CECR1 |
0.9 |
NT5C3A |
NT5M |
0.9 |
UPRT |
NT5C1A |
0.9 |
NT5C3B |
NT5C |
0.9 |
NT5C1B |
NAMPT |
0.9 |
NT5C3A |
UPRT |
0.9 |
ENSG00000250741 |
ADK |
0.9 |
ENSG00000250741 |
CDA |
0.9 |
NT5C1A |
NAMPT |
0.9 |
ENSG00000250741 |
HPRT1 |
0.9 |
NT5C3B |
UPRT |
0.9 |
ENSG00000250741 |
UPRT |
0.9 |
CDA |
NT5C1B |
0.9 |
ENSG00000250741 |
DCK |
0.9 |
NT5C1B |
HPRT1 |
0.9 |
NT5C3B |
APRT |
0.9 |
UPRT |
NT5C1B |
0.9 |
NT5C3A |
TK1 |
0.9 |
UPRT |
NT5C2 |
0.9 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
9627 (SNCAIP) |
2861 (GPR37) |
5071 (PARK2) |
2812 (GP1BB) |
54584 (GNB1L) |
5413 (SEPT5) |
9627 (SNCAIP)
|
1.00
|
0.65
|
0.69
|
0.79
|
0.48
|
0.66
|
2861 (GPR37)
|
0.65
|
1.00
|
0.65
|
0.80
|
0.48
|
0.52
|
5071 (PARK2)
|
0.69
|
0.65
|
1.00
|
0.64
|
0.48
|
0.63
|
2812 (GP1BB)
|
0.79
|
0.80
|
0.64
|
1.00
|
0.48
|
0.60
|
54584 (GNB1L)
|
0.48
|
0.48
|
0.48
|
0.48
|
1.00
|
0.64
|
5413 (SEPT5)
|
0.66
|
0.52
|
0.63
|
0.60
|
0.64
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
PNP |
Toad |
Liver |
- |
3464 m |
33 day |
upregulated |
3.0933543 |
RNA-seq |
Tibetan Plateau |
Asiatic toad |
1 |
Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - |
28673260 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
4860 |
GO:0034418 |
urate biosynthetic process |
GOTERM_BP_DIRECT |
4860 |
GO:0001882 |
complement component C1q binding |
GOTERM_MF_DIRECT |
4860 |
GO:0070970 |
interleukin-2 secretion |
GOTERM_BP_DIRECT |
4860 |
GO:0002060 |
p53 binding |
GOTERM_MF_DIRECT |
4860 |
GO:0005856 |
cytoskeleton |
GOTERM_CC_DIRECT |
4860 |
GO:0043101 |
purine-containing compound salvage |
GOTERM_BP_DIRECT |
4860 |
GO:0004731 |
protein tyrosine phosphatase activity |
GOTERM_MF_DIRECT |
4860 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
4860 |
GO:0006738 |
nicotinamide riboside catabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0009116 |
nucleoside metabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0005622 |
intracellular |
GOTERM_CC_DIRECT |
4860 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
4860 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway |
GOTERM_BP_DIRECT |
4860 |
GO:0042102 |
positive regulation of T cell proliferation |
GOTERM_BP_DIRECT |
4860 |
GO:0005829 |
cytosol |
GOTERM_CC_DIRECT |
4860 |
GO:0005576 |
extracellular region |
GOTERM_CC_DIRECT |
4860 |
GO:0006148 |
inosine catabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0042278 |
purine nucleoside metabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0046638 |
positive regulation of alpha-beta T cell differentiation |
GOTERM_BP_DIRECT |
4860 |
GO:0003824 |
catalytic activity |
GOTERM_MF_DIRECT |
4860 |
GO:0006195 |
purine nucleotide catabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0006139 |
nucleobase-containing compound metabolic process |
GOTERM_BP_DIRECT |
4860 |
GO:0006955 |
immune response |
GOTERM_BP_DIRECT |
4860 |
GO:0042301 |
MHC class I protein binding |
GOTERM_MF_DIRECT |
4860 |
GO:0042493 |
response to drug |
GOTERM_BP_DIRECT |
4860 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
4860 |
GO:0008144 |
drug binding |
GOTERM_MF_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
4860 |
hsa00240 |
Pyrimidine metabolism |
4860 |
hsa00230 |
Purine metabolism |
4860 |
hsa00760 |
Nicotinate and nicotinamide metabolism |
4860 |
hsa01100 |
Metabolic pathways |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
PNP |
4860 |
Osteoporosis |
C0029456 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Arsenic Poisoning, Inorganic |
C0274861 |
Injury or Poisoning |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Arsenic Encephalopathy |
C0751851 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Arsenic Induced Polyneuropathy |
C0751852 |
Injury or Poisoning |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Nervous System, Organic Arsenic Poisoning |
C0274862 |
Injury or Poisoning |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Osteoporosis, Senile |
C0029459 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Post-Traumatic Osteoporosis |
C0751406 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Hepatitis, Drug-Induced |
C1262760 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Arsenic Poisoning |
C0311375 |
Injury or Poisoning |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Drug-Induced Acute Liver Injury |
C3658290 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Drug-Induced Liver Disease |
C0860207 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Osteoporosis, Age-Related |
C0001787 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Hepatitis, Toxic |
C0019193 |
Injury or Poisoning |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Chemically-Induced Liver Toxicity |
C4279912 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Chemical and Drug Induced Liver Injury |
C4277682 |
Disease or Syndrome |
0.3 |
0.545 |
0.793 |
disease |
PNP |
4860 |
Purine-nucleoside phosphorylase deficiency |
C0268125 |
Disease or Syndrome |
0.93 |
0.545 |
0.793 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
PNP |
4860 |
FORODESINE |
FORODESINE |
CHEMBL218291 |
None |
PNP |
4860 |
FORODESINE HYDROCHLORIDE |
FORODESINE HYDROCHLORIDE |
CHEMBL550755 |
inhibitor |
PNP |
4860 |
FORODESINE |
FORODESINE |
CHEMBL218291 |
inhibitor |
PNP |
4860 |
ULODESINE |
ULODESINE |
CHEMBL269864 |
None |